CClinicalTrials.gg
CompletedNCT03320668Updated Aug 3, 2022

Efficacy of the Otago Exercise Program Delivered as Group Training Versus Individually Tailored Training

An interventional study of Otago Exercise Program (OEP) in Age Problem, sponsored by Instituto de Salud Carlos III. Completed at 9 sites in Spain. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-08-03.

Sponsored by Instituto de Salud Carlos III · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
878
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

A non-inferiority controlled clinical trial using randomization for allocation at the level of general practice in 21 centers (in 8 Spanish regions), to compare a group Otago exercise program (OEP) [delivered by specifically trained instructors and supplemented by prescriptive recommendations for home exercising], with an individual OEP [also delivered by specifically trained professionals and supplemented by prescriptive recommendations for home exercising], with twelve months follow-up to determine the effectiveness of the OEP in terms of prevention of falls in a community-dwelling 65- to 80-year-old population.

Read the detailed description

OBJECTIVES:

To compare the effectiveness of the Otago Exercise Program (OEP) delivered as group training versus individually tailored training in community-dwelling adults between 65 and 80 years old, on the probability of falls, improved functional balance and muscle strength and, quality of walk in the 12 months follow up.

To compare the effectiveness of both interventions to improve dynamic and static balance and gait quality in the same population.

DESIGN:

Non-inferiority clinical trial, multicentric, simple blind (blind analysis to prevent bias), with two interventions, implementation of group and individual OEP with random assign. The follow-up period will be twelve months after the OEP training.

FIELD OF STUDY:

21 Primary Health Centers (PHC) belonging to the National Health System in 8 different regions: Andalucía, Asturias, Islas Baleares, Canarias, Cataluña, Comunidad de Madrid, Región de Murcia and País Vasco

PARTICIPANTS:

Subjects who belong to primary care centers in the same health area, 65 to 80 years of age, who are not institutionalized, independent for walk (the score of the first part of the Short Physical Performance Battery scale (SPPB scale) in relation to balancing must be different from zero in any assessed position) and provide informed consent to participate in the study.

VARIABLES OF STUDY:

Principal Outcome: Percentage of falls (percentage of subjects falling)

Other Outcomes:

Safety of Intervention; Feasibility of interventions; Feasibility of the cascade training model based on the OEP; Economic analysis and added therapeutic value of both interventions.

DATA COLLECTION:

Subjects will be selected from the health centers through active recruitment by the health professionals.

The recruitment will be consecutive among the patients in the agenda in the days between 10 to 19 of each month from September 2017-December 2018.

Data will be collected at month 0, 6 and 12. Randomization will be performed by PHC and by subjects.

DATA ANALYSIS:

A descriptive analysis of sociodemographic and fall variables will be performed. The analysis to the comparative data between the two groups of the Randomize Clinical Trial will be done by protocol. In addition, an analysis will be made for the incidence density of falls, using Poisson regression models. For all a confidence level of 95% will be assumed, and the statistical software to be used to carry out the analysis will be Statistical Package for the Social Sciences version 22 (SPSS v22).

02

Conditions studied

  • Age Problem

Keywords

  • Falls Prevention
  • Otago Program
  • Community-Dwelling
03

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjects who belong (ascribed) to primary healthcare centers of the same health area, aged 65 to 80 years, non-institutionalized, independents for ambulation (the scores achieved from the first part of SPPB scale in relation of the balance will be different from zero in any position evaluated.) and provide their informed consent for participating in the study.

Exclusion criteria

Exclusion Criteria:

  • Subject such residential period in the Health Basic Area of the primary health center or it life expectancies has lower 9 months. in the health area of the primary healthcare center.
  • Mild and moderate cognitive impairment (according to the diagnosis from medical history).
  • Sight-impairment or hearing impairment which prevent to follow the intervention (according to the diagnosis from medical history).
  • Absolute contraindication to perform physical exercise (according to the diagnosis from medical history)
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
878 participants (actual)

Study arms

  • No intervention
    Individual OEP

    Randomized subjects (65 to 80-year-old) receiving individual Otago Exercise Program (OEP) training in a total of nine Primary Care Centers. An "OEP leader" trained nurse/physiotherapist will perform in its community consult individual education to each participant in five sessions: In the 1st, 2nd, 4th and 8th week and one reinforcement session after six months. A telephone call to each participant (following a predefined telephonic interview protocol) will be carried out in the months without training session to perform the follow-up.

  • Experimental
    Group OEP

    65-80 year-old randomized subjects receiving group Otago Exercise Program (OEP) training in a total of nine Primary Care Centers.

    Other: Otago Exercise Program (OEP)

Interventions

  • OtherOtago Exercise Program (OEP)

    A nurse/physiotherapist supported by an "instructor"-trained professional will give Otago Exercise Program (OEP) education to 10-people groups in 5 sessions (1st, 2nd, 4th and 8th week and one reinforcement session after 6 months). Telephone calls to participants will be made during non-training months (following a predefined telephonic interview protocol) to follow up. The OEP reduces the number of falls and fall-related injuries, improving balance and strength, confidence in performing everyday activities without falling. Whilst it has been shown to be effective in 4 controlled trials in New Zealand, it has not been tested in a primary care setting in Spain for feasibility, impact, acceptability and cost-effectiveness.

    Also known as: Usual Practice

05

What researchers measure

Primary outcomes

  1. Percentage of falls

    The participant will be provided with a notebook which should be completed each month. In the case a fall occur, the patient will be asked to fill the following items regarding the fall characteristics: Data, place, context in which the fall happened, consequences and attention required.

    Time frame: 12 months

Secondary outcomes

  1. Adverse events

    1. Adverse events during the intervention related to exclusion criteria (indication for a subject to leave the project) 2. Adverse effects which can be directly or potentially associated with Otago exercises. For that, it will be established an external committee which will classify the adverse event among related, potentially related and none related with Otago exercise execution.

    Time frame: 12 months

  2. Adherence

    Adherence level to exercise program will be measured following the Exercise Adherence Rating Scale (EARS) through self-declared falls diary. The EARS questionnaire is composed of 6 items, each of them is scaled from 0 (minimum) to 4 (maximum score). Total score is the sum of the 6 items, so that it ranges from a minimum score of 0 and a maximum score of 64. Adherence measurements will be collected at 6 and 12 months.

    Time frame: 12 months

  3. Participant satisfaction

    Participant satisfaction with the intervention will be measured through "ad hoc" survey which include the following items: 4.1. Received information about exercise program and its benefits 4.2. Received Training about Otago Exercise Program 4.3. Assessment of Material 4.4. Teaching skills of your OEP trainer 4.5. Receptiveness of your health care professional to solve your doubts about the OEP 4.6. Global satisfaction with Otago Exercise Program Each item will be scaled from 0 (Totally unsatisfied) to 4 (Very satisfied). Total minimum and maximum scores are 0 and 64, respectively.

    Time frame: 12 months

06

Study locations

9 sites
  • Osakidetza
    Vitoria, Araba Kalea, 45, Vitoria-Gasteiz 01006, Spain
  • Universidad de Córdoba
    Córdoba, Av. De Medina Azahara, 5 14005, Spain
  • Servicio de Salud de Madrid
    Madrid, Avenida Abrantes, 55 28025, Spain
  • Servicio de Salud de Canarias
    Palmas de Gran Canaria, Avenida Juan Xxiii,17 35071, Spain
  • Servicio Murciano de Salud
    Murcia, Calle Central, 7, Espinardo 30100, Spain
  • Servei de Salut de Les Illes Balears
    Palma de Mallorca, Carrer De La Reina Esclaramunda, 9, Palma 07003, Spain
  • Institut Català de la Salut (ICS)
    Barcelona, Gran Via De Les Corts Catalanes, 587-589 08004, Spain
  • Institut Català de la Salut
    Barcelona, Gran Via De Les Corts Catalanes, 587-589 08004, Spain
  • Servicio de Salud del Principado de Asturias
    Oviedo, Plaza Del Carbayón, Oviedo 33001, Spain
07

References and documents

Publications

  • Angeles CM, Laura AM, Consuelo CM, Manuel RR, Eva AC, Covadonga GA; Otago Project Working Group. The effect that the Otago Exercise Programme had on fear of falling in community dwellers aged 65-80 and associated factors. Arch Gerontol Geriatr. 2022 Mar-Apr;99:104620. doi: 10.1016/j.archger.2022.104620. Epub 2022 Jan 4. PubMed 34999543 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03320668
Lead sponsor
Instituto de Salud Carlos III
Collaborators
Fondo de Investigacion Sanitaria, Osakidetza, MurciaSalud
Responsible party
Teresa Moreno Casbas (Unit Director, Instituto de Salud Carlos III) — Principal investigator
First posted
Oct 25, 2017
Start date
Jan 10, 2017
Primary completion
Dec 30, 2021
Completion
Feb 28, 2022
Last update
Aug 3, 2022

Study contacts

Teresa Moreno-Cascas, Doctor
study director · Instituto de Salud Carlos III

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion